Garo Armen

Insider profile

Currently holds positions in Protagenic Therapeutics Inc and Agenus Inc

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 36% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
12 92% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -79%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chairman of the Board Protagenic Therapeutics Inc Feb. 12, 2016 -
Chairman of the Board, Chief Executive Officer, Co-Founder Agenus Inc Jan. 1, 1994 -
Garo Armen's trades of Protagenic Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
402.65
Quantity 3,247 -20.9%
Value US$1,197,157
Transaction date
Purchase
Price
201.54
Quantity 65,878 -38.8%
Value US$2,247,561
Transaction date
Purchase
Price
336.99
Quantity 31,225 -16.9%
Value US$3,313,572
Transaction date
Purchase
Price
0.32
Quantity 2,220 +6.9%
Value US$710
Transaction date
Purchase
Price
0.22
Quantity 685 +2.2%
Value US$151
Transaction date
Purchase
Price
0.26
Quantity 5,000 +19.0%
Value US$1,294
Transaction date
Purchase
Price
0.18
Quantity 26,291 New position
Value US$4,806
US Agenus Inc (AGEN)
Transaction date
Purchase
Price
0.65
Quantity 500,000 +396.9%
Value US$324,050
Transaction date
Sale
Price
0.95
Quantity 100,000 -5.1%
Value US$94,850
Transaction date
Purchase
Price
0.95
Quantity 100,000 +5.3%
Value US$94,850
US Agenus Inc (AGEN)
Transaction date
Sale
Price
6.50
Quantity 82,107 -9.6%
Value US$533,696
US Agenus Inc (AGEN)
Transaction date
Purchase
Price
6.39
Quantity 25,000 +0.2%
Value US$159,760
US Agenus Inc (AGEN)
Transaction date
Purchase
Price
4.74
Quantity 100,000 +0.9%
Value US$474,300
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-24 2026-08-21
B Purchase
3,247 -20.9%
402.65
US$1,197,157 		3,247 -20.9% 402.65 US$1,197,157
2026-08-20 2026-08-20
B Purchase
65,878 -38.8%
201.54
US$2,247,561 		65,878 -38.8% 201.54 US$2,247,561
2026-08-20 2026-08-19
B Purchase
31,225 -16.9%
336.99
US$3,313,572 		31,225 -16.9% 336.99 US$3,313,572
2026-08-12 2026-08-11
B Purchase
2,220 +6.9%
0.32
US$710 		2,220 +6.9% 0.32 US$710
2026-08-10 2026-08-06
B Purchase
685 +2.2%
0.22
US$151 		685 +2.2% 0.22 US$151
2026-08-06 2026-08-05
B Purchase
5,000 +19.0%
0.26
US$1,294 		5,000 +19.0% 0.26 US$1,294
2026-08-03 2026-07-30
B Purchase
26,291 New position
0.18
US$4,806 		26,291 New position 0.18 US$4,806
2024-02-15 2024-02-15
US Agenus Inc (AGEN)
B Purchase
500,000 +396.9%
0.65
US$324,050 		500,000 +396.9% 0.65 US$324,050
2023-05-05 2023-05-05
S Sale
100,000 -5.1%
0.95
US$94,850 		100,000 -5.1% 0.95 US$94,850
2023-05-04 2023-05-02
B Purchase
100,000 +5.3%
0.95
US$94,850 		100,000 +5.3% 0.95 US$94,850
2021-09-14 2021-09-13
US Agenus Inc (AGEN)
S Sale
82,107 -9.6%
6.50
US$533,696 		82,107 -9.6% 6.50 US$533,696
2004-10-28 2004-10-27
US Agenus Inc (AGEN)
B Purchase
25,000 +0.2%
6.39
US$159,760 		25,000 +0.2% 6.39 US$159,760
2004-10-21 2004-10-21
US Agenus Inc (AGEN)
B Purchase
100,000 +0.9%
4.74
US$474,300 		100,000 +0.9% 4.74 US$474,300